In the CA COST Action Cancer nanomedicine - from the bench to the bedside (CA17140), will provide a timely instrument to rationalize and focus research efforts at the EU level in dealing with the grand challenge of nanomedicine translation in cancer, one of the major and societal-burdening human pathologies.
More about this COST Action in
In the CA COST Action International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches (CA17116), will unite a currently fragmented a critical mass of academic, clinical, and industry expertise to enhance both basic understanding and translational potential of perinatal derivatives.
More about this COST Action in